Atlas Trials

Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis

Clinical trial NCT02245841 · COMPLETED

Trial details

NCT number
NCT02245841
Sponsor
The Cleveland Clinic
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
DermatomyositisJuvenile Dermatomyositis
Start date
2015-06-15
Primary completion
2021-07-14
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.